surfaxin is a breakthrough for SIDS. the future is bright. in the mid-term, i plan to hold some for mid-4th quarter to realize some nice gains. for the short term, i will be more focusing on financials tomorrow. see what C did in the last minute?
one thing to note that the company may run out of money before FDA approves. It's a risk bearing in mind.